Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 3, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Sickle Cell DiseaseSickle Cell AnemiaInsomniaSleeplessnessTransient InsomniaNonorganic InsomniaChronic Insomnia
Interventions
BEHAVIORAL

ACT Intervention

1-week baseline data collection period followed by an 8-week ACT intervention period focusing on acceptance, cognition defusion (i.e., not letting thoughts about sleep control behavior), present moment awareness, perspective taking, values, and committed actions.

BEHAVIORAL

Waitlist

1-week baseline data collection period followed by 8 weeks of maintaining usual routine followed by an 8-week intervention focusing on acceptance, cognition defusion (i.e., not letting thoughts about sleep control behavior), present moment awareness, perspective taking, values, and committed actions.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH